Stay updated on Vemurafenib+Cobimetinib Beyond Progression in BRAF+ Melanoma Clinical Trial
Sign up to get notified when there's something new on the Vemurafenib+Cobimetinib Beyond Progression in BRAF+ Melanoma Clinical Trial page.

Latest updates to the Vemurafenib+Cobimetinib Beyond Progression in BRAF+ Melanoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedNew location sections for multiple Italian sites (BA, BG, BO, FC, GE, ME, MI, PD, PI, SI, TO) have been added and the page revision updated to v3.3.3. The previous location blocks and the HHS Vulnerability Disclosure link have been removed.SummaryDifference1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.2, indicating a minor template/software update; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check48 days agoChange DetectedRemoved the government funding notice about operating status. The study details and eligibility criteria remain unchanged.SummaryDifference0.3%

- Check62 days agoChange DetectedThe page content appears unchanged; observed differences are minor UI/formatting adjustments that do not affect core study information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check91 days agoChange DetectedAdded a government-status notice and a version upgrade to v3.2.0; removed v3.1.0.SummaryDifference2%

- Check98 days agoChange DetectedUpgrade applied: version updated from v3.0.2 to v3.1.0. No other substantive content changes detected.SummaryDifference0.1%

Stay in the know with updates to Vemurafenib+Cobimetinib Beyond Progression in BRAF+ Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vemurafenib+Cobimetinib Beyond Progression in BRAF+ Melanoma Clinical Trial page.